Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
VEGF-A and FLT-1 tumour gene e...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy
書目詳細資料
Main Authors:
Brueckl, WM
,
Wirtz, R
,
Dimmler, A
,
Brunner, T
,
Klein, P
,
Hahn, E
,
Ficker, J
,
Wiest, G
格式:
Journal article
出版:
2009
持有資料
實物特徵
相似書籍
職員瀏覽
相似書籍
TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
由: Papadopoulos Thomas, et al.
出版: (2007-08-01)
Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
由: Jin Yujuan, et al.
出版: (2023-05-01)
Development and Validation of a Simplified Prognostic Score in SCLC
由: Elodie Negre, MD, et al.
出版: (2020-03-01)
Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
由: Jiaping Liu, et al.
出版: (2024-06-01)
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
由: Kana Hashimoto, MD, et al.
出版: (2024-11-01)